Recent Articles

• How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

   Posted on March 8, 2023

  In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.

• Ginny Ruffner and Dr. Jim Heath Explore the Intersection of Art and Science

   Posted on January 23, 2023

  Renowned artist Ginny Ruffner and ISB President Dr. Jim Heath delivered a lecture at Town Hall Seattle about the intersection of art and science. They spoke about how creation stories tie scientists and artists together, and how their approaches are both similar and different from that point on.

• In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

   Posted on November 10, 2022

  Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.